Fuso Chemical Co., Ltd.TSE: 4368

Financial results briefing for the second quarter ended September 30, 2023 (for Institutional Investors)

Nov 13, 2023 at 11:00 PM UTC · Issued by Fuso Chemical Co., Ltd.

FY03/2024 2nd Quarter Financial Results

Period from April 1,2023 to

September 30,2023

November 14, 2023

Prime market（4368）

Tokyo Stock Exchange, Inc.

Table of Contents

Financial Summary Results for 2nd Quarter (period April 1, 2023 - September 30, 2023)

Segments Results ■Life Science
■Electronic Materials & Functional Chemicals

III.FY03/2024 Outlook

(period April 1, 2023 - March 31, 2024)

I. FY03/2024 1H Financial Summary

(period April 1, 2023 - September 30, 2023)

Consolidated Financial Results for FY03/2024 1H

	FY03/2024
（unit：100 millions of yen）	1H

	vs FY03/2023		Budget disclosed in May 2023		Budget disclosed in Sep.2023
FY03/2023	YoY	YoY ratio		Budget	Change vs budget	Budget	Change vs budget
1H

Net sales	271.3	353.5	△82.2	△23.3% ↘	336.0	△64.6	△19.2%	274.0	△2.6	△1.0%

Operating profit	55.8	95.7	△39.9	△41.7% ↘	71.0	△15.1	△21.4%	55.0	＋0.8	＋1.5%

Ordinary profit	62.4	107.5	△45.1	△41.9% ↘	71.0	△8.5	△12.0%	60.5	＋1.9	＋3.2%

Profit attributable to	42.8	75.1	△32.2	△43.0% ↘	48.5	△5.6	△11.6%	41.0	＋1.8	＋4.6%
owners of parent


EBITDA	83.6	116.2	△32.5	△28.0% ↘	101.5	△17.8	△17.6%	82.5	＋1.1	＋1.4%

Earnings per	¥121.6	¥213.2	¥△91.6	△43.0% ↘	¥137.6	¥△15.9	△11.6%	¥116.3	¥5.3	＋4.6%
share

Sales & Profit by segment

versus previous year FY03/2023 1H

			vs FY03/2023 1H

(unit:100 millions of yen)	3/'24 1H	3/'23 1H	change	Ratio
▬Life Science	Net sales	169.7	193.7	△23.9		△12.4% ↘
	32.7
	Operating profit	33.4	△0.7		△2.1% ↘

▬Electronic Materials &	Net sales	101.5	159.8	△58.2		△36.4% ↘

Functional Chemicals	Operating profit	33.3	71.4	△38.1		△53.4% ↘


(Adjustment)	△10.2	△9.1	△1.0	―

Operating pfofit (consolidated)	55.8	95.7	△39.9		△41.7% ↘

FY03/2024 Quarterly Results

	3/'24	YonY	3/'24	YonY
（unit：100 ｍillions of yen）	１Q	change	ratio	２Q	change	ratio

Net sales	136.4	△39.0	△22.2%	134.9	△43.2	△24.3%

Operating profit	31.9	△14.9	△31.9%	23.8	△24.9	△51.1%

Ordinary profit	37.2	△16.3	△30.5%	25.1	△28.7	△53.3%

Profit attributable	24.5	△12.0	△33.0%	18.3	△20.2	△52.4%
to owners of parent


EBITDA	41.8	△14.9	△26.4%	41.8	△17.5	△29.6%

Earnings per	¥69.6	¥△34.2	¥52.0	¥△57.3
share

FY03/2024 Quarterly Results Trends

	（100 millions of
700	yen）
		４Q


600			３Q


		２Q


500			１Q



	413	422

400
	100	110
300
	109	108

Net Sales

557

161

144

684

605

158

172

178

	（100 millions of	Operating Profit
200	yen）	189

			４Q
180


		３Q			42



160			２Q		150


		１Q
140


120					47	51	109


100	88		96


80	18		24	38
				48

200		123

103	101
100
99	102	128

134

175 136

60	25	25
	30
40			23
22	22

20			33	46
	21	23	31

3/'20

3/'21

3/'22

3/'23

3/'24

0
3/'20	3/'21	3/'22	3/'23	3/'24

Net Sales by Segment

400 （100 millions of yen）

350		Electronic Materials &

300	Functional Chemicals
Life Science
					159
250							146
					136
								101
200					107

150	80	91	90	97

100					144	169	193	184	169
	123			120
50	117	113

0
	1H	2H	1H	2H	1H	2H	1H	2H	1H	2H plan
		3/'20	3/'21			3/'22		3/'23		3/'24

Operating Profit by Segment

110 (100 millions of yen) Electronic Materials & Functional Chemicals

Life Science

90	(Adjustment)	Electronic Materials


	profit ratio

Life Science profit ratio

70							71	62

						65
50					50				33


30	26	31	35	40

						28	33	40	32
10	23	19			20
17	15


△ 10	-6	-6	-6	-6	-6	-8	-9	-9	-10

	1H	2H	1H	2H	1H	2H	1H	2H	1H	2H plan

3/'20

3/'21

3/'22

3/'23

3/'24

60%

50%

40%

30%

20%

10%

Net Profit Analysis FY03/2022 versus FY03/2023

increase

decrease

（unit:100 millions of yen）

				selling, general
3/'23	net sales	CGS	CGS	and	non‐operating	extraordinary	income taxes	3/'24
net profit		(other)	(depreciation) administrative	profit or loss	profit or loss		net profit

expenses